Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

August 17, 2023
BioUtah News
BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

Revi redefines the treatment of Urgency Incontinence with a patient-centric implantable tibial neuromodulation solution that empowers patients

August 17, 2023
BioUtah News
Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

August 17, 2023
BioUtah News
August 17, 2023
BioUtah News
Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1

August 10, 2023
BioUtah News
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances were made possible by NVIDIA DGX Cloud supercomputing and the recent acquisition of Cyclica’s MatchMaker technology.

August 10, 2023
BioUtah News
Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery

August 7, 2023 Four years ago, Jacob Sheffield was building world-class carbon fiber travel guitars for adventurers journeying to places as remote as Everest and Antarctica. Ian Esplin was growing viruses in bioreactors and developing therapies to combat antibiotic-resistant pathogens. The two came together and co-founded Bloom Surgical with a goal to empower robotic surgeons […]

August 10, 2023
BioUtah News
August 10, 2023
BioUtah News
Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

ComboMATCH study uses genetic testing to match advanced cancer patients with targeted treatments

August 3, 2023
BioUtah News
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes and chronic kidney disease

August 3, 2023
BioUtah News
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis […]

August 3, 2023
BioUtah News
Alucent Biomedical Wins FDA Approval for U.S. Clinical Study

U.S. FDA Grants an Investigational Device Exemption for Trial Evaluating Novel AlucentNVS Technology

August 3, 2023
BioUtah News
Quansys Biosciences and The Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research

Quansys Biosciences and The Michael J. Fox Foundation, announced a strategic partnership to accelerate research into PD.

August 2, 2023
BioUtah News
Government Price Setting Would Lead to Lost Therapies, Innovation and Jobs in Utah

New Study Details Proposed Federal Government-Mandated Drug Pricing Policies Senate SMART Prices Act Will Cost More Than 235 Fewer FDA Approvals Up To 23,000 Lost Jobs in Utah in Coming Decade SALT LAKE CITY, July 27, 2023 – Proposed expansions of federal government-mandated drug pricing policies present serious consequences for the development of and investment in […]

July 27, 2023
BioUtah News
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic machine learning research through scholarships and fellowships.SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding […]

July 27, 2023
BioUtah News
DEVICE FOR TREATING CHALLENGING BONE FRACTURES CLEARED BY FDA

A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. Food and Drug Administration (FDA), the University of Utah Orthopaedic Innovation Center (OIC), Department of Orthopaedics and Spencer Fox Eccles School of Medicine announced on July 20, 2023. “This achievement demonstrates the commitment by the […]

July 27, 2023
BioUtah News
Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, today announces the appointment of executive Jonathan Harris as its new President and Chief Revenue Officer. Harris joins Owlet at a pivotal time in its business – one month after receiving clearance from the U.S. Food and Drug […]

July 27, 2023
Policy News
Bloom Surgical Awarded Competitive Grant from the NSF

Funding accelerates development of device for resolving visual disruptions in robotic procedures Salt Lake City, UT, June 1, 2023 – Bloom Surgical, Inc., a Utah-based surgical device startup, has been awarded a U.S. National Science Foundation Small Business Innovation Research grant for $256,000 to conduct research and development work on a novel micro-mechanical wiping mechanism […]

July 27, 2023
BioUtah News
Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers. This comprehensive model is expected to identify more patients that could benefit from a change in their breast care.

July 27, 2023
BioUtah News
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, auto-identification, dose error reduction software and EMR interoperability BD Alaris™ Infusion System’s unique “One System” platform securely connects all patient modules to provide care teams […]

July 27, 2023
BioUtah News
Renalytix Announces Middle East Distribution Agreement with Vector Pharma

Distribution agreement opens kidneyintelX.dkd testing to address early-stage kidney disease in region with one of the highest incidence rates for type 2 diabetes globally

July 20, 2023
Policy News
Rep. Moore Calls For Increased Transparency in the NCD Process

Utah U.S. Rep. Blake Moore (R-UT) signed onto a letter to HHS/CMS, led by House Ways and Means Committee Chair Jason Smith (R-MO) and House Energy and Commerce Committee Chair Kathy McMorris-Rodgers (R-WA), calling for increaed transparency in the NCD process following the agency’s recent release of the TCET notice. In part, the letter states, […]

July 20, 2023
BioUtah News
Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (NYSE: OWLT, “the Company”), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company’s Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. […]

July 20, 2023
BioUtah News
Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program

The Company intends to use the funds awarded by the National Institutes of Health for completion of its upper respiratory panel multiplex on Co-Dx PCR Home™ platform SALT LAKE CITY, July 13, 2023 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development […]

July 20, 2023
BioUtah News
Co-Diagnostics, Inc. Announces Recent Grant Awards

The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis and HPV tests for its Co-Dx PCR Home™ platform  SALT LAKE CITY, July 18, 2023 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of […]